Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer

Detalles Bibliográficos
Main Authors:	Church, D, Domingo, E, Sieber, O, Ramamoorthy, R, Davidson, B, Kerr, D, Midgley, R, Tomlinson, I
Formato:	Conference item
Publicado:	2013

Títulos similares